General Information of the Compound
Compound ID
CP0074738
Compound Name
(S)-(+)-N-((3-[1-Benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]prop-1-yl)-4-phenylpiperidin-4-yl)-N-methylacetamine
    Show/Hide
Synonyms
Osanetant [INN]
160492-56-8
CHEMBL346178
K7G81N94DT
N-(1-(3-((3R)-1-benzoyl-3-(3,4-dichlorophenyl)-3-piperidinyl)propyl)-4-phenyl-4-piperidinyl)-N-methylacetamide
N-(1-(3-((R)-1-Benzoyl-3-(3,4-dichlorophenyl)-3-piperidyl)propyl)-4-phenyl-4-piperidyl)-N-methylacetamide
N-(1-{3-[(3r)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl}-4-phenylpiperidin-4-yl)-n-methylacetamide
N-[1-[3-[(3R)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl]-4-phenylpiperidin-4-yl]-N-methylacetamide
Osanetant
Osanetant [INN]
SB-236984
SR 142801
SR-14280
SR-142801
SR-142806
SR142801
UNII-K7G81N94DT
[3H]osanetant
n-(1-{3-[(3r)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl}-4-phenylpiperidin-4-yl)-n-methylacetamide
    Show/Hide
Structure
Formula
C35H41Cl2N3O2
Molecular Weight
606.638
Canonical SMILES
CN(C(C)=O)C1(CCN(CCC[C@@]2(CCCN(C2)C(=O)c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C35H41Cl2N3O2/c1-27(41)38(2)35(29-13-7-4-8-14-29)19-23-39(24-20-35)21-9-17-34(30-15-16-31(36)32(37)25-30)18-10-22-40(26-34)33(42)28-11-5-3-6-12-28/h3-8,11-16,25H,9-10,17-24,26H2,1-2H3/t34-/m0/s1
    Show/Hide
InChIKey
DZOJBGLFWINFBF-UMSFTDKQSA-N
CAS
160492-56-8
Physicochemical Property
logP
7.4172
Rotatable Bonds
8
Heavy Atom Count
42
Polar Areas
43.86
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
42

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 219077
SID: 57304375
ChEMBL ID
CHEMBL346178
DrugBank ID
DB04872
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01199, Neuromedin-K receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  3
1
IC50 = 0.21 nM
   TI
   LI
   LO
   TS
2
Ki = 1.2 nM
   TI
   LI
   LO
   TS
3
Ki = 1.585 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  12
1
Kd = 0.2 nM
   TI
   LI
   LO
   TS
2
Kd = 0.22 nM
   TI
   LI
   LO
   TS
3
Kd = 5.888 nM
   TI
   LI
   LO
   TS
4
Kd = 16.98 nM
   TI
   LI
   LO
   TS
5
Kd = 18.62 nM
   TI
   LI
   LO
   TS
6
Kd = 29.51 nM
   TI
   LI
   LO
   TS
7
Ki = 0.4 nM
   TI
   LI
   LO
   TS
8
Ki = 0.5 nM
   TI
   LI
   LO
   TS
9
Ki = 0.6 nM
   TI
   LI
   LO
   TS
10
Ki = 2.1 nM
   TI
   LI
   LO
   TS
11
Ki = 4.8 nM
   TI
   LI
   LO
   TS
12
Ki = 10.8 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 0.1995 nM
2 Ki = 1.9 nM
Protein ID: PT05029, Neuromedin-K receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  5
1
Kd = 0.08 nM
   TI
   LI
   LO
   TS
2
Kd = 0.15 nM
   TI
   LI
   LO
   TS
3
Kd = 3.162 nM
   TI
   LI
   LO
   TS
4
Ki = 0.6 nM
   TI
   LI
   LO
   TS
5
Ki = 0.8 nM
   TI
   LI
   LO
   TS
Protein ID: PT01290, Substance-K receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  2
1
Ki = 1.568202 nM
   TI
   LI
   LO
   TS
2
Ki = 40.3 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 35.5 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 79.43 nM
2 Ki = 85 nM
Protein ID: PT01410, Substance-P receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 209.6 nM
   TI
   LI
   LO
   TS
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 1300 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 330 nM
2 Ki = 398.11 nM
Clinical Information about the Compound
Drug 1 ( Osanetant )
Drug Name Osanetant
Company Sanofi-aventis
Indication
Schizoaffective disorder
Discontinued in Phase 2b
Schizophrenia
Discontinued in Phase 2b
Depression
Terminated
Target(s)
Neuromedin-K receptor (TACR3)
Antagonist